Video: COVID-19 vaccine`s efficacy rate above 90%, claims Pfizer in first interim analysis from Phase 3 study

"Based on current projections we expect to produce globally up to 50 million COVID-19 vaccine doses in 2020 and up to 1.3 billion doses in 2021," said Pfizer.